Herzog TJ - Search Results

1

Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.

Buttin BM, Powell MA, Mutch DG, Rader JS, Herzog TJ, Gibb RK, Huettner P, Edmonston TB, Goodfellow PJ. Buttin BM, et al. Among authors: herzog tj. Clin Cancer Res. 2004 Jan 15;10(2):481-90. doi: 10.1158/1078-0432.ccr-1110-03. Clin Cancer Res. 2004. PMID: 14760069

2

The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.

Mutch DG, Herzog TJ, Chen CA, Collins JL. Mutch DG, et al. Among authors: herzog tj. Gynecol Oncol. 1992 Oct;47(1):28-33. doi: 10.1016/0090-8258(92)90070-y. Gynecol Oncol. 1992. PMID: 1427396

3

Effects of radiation on TNF alpha-mediated cytolysis of cell lines derived from cervical carcinomas.

Herzog TJ, Nelson PK, Mutch DG, Wright WD, Kao MS, Collins JL. Herzog TJ, et al. Gynecol Oncol. 1992 Nov;47(2):196-202. doi: 10.1016/0090-8258(92)90106-s. Gynecol Oncol. 1992. PMID: 1468697

4

Low frequency of CDKN2 mutation in endometrial carcinomas.

Peiffer SL, Bartsch D, Whelan AJ, Mutch DG, Herzog TJ, Goodfellow PJ. Peiffer SL, et al. Among authors: herzog tj. Mol Carcinog. 1995 Aug;13(4):210-2. doi: 10.1002/mc.2940130403. Mol Carcinog. 1995. PMID: 7646759

5

Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.

Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, Goodfellow PJ. Peiffer SL, et al. Among authors: herzog tj. Cancer Res. 1995 May 1;55(9):1922-6. Cancer Res. 1995. PMID: 7728760

6

Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasia.

Herzog TJ, Williams S, Adler LM, Rader JS, Kubiniec RT, Camel HM, Mutch DG. Herzog TJ, et al. Gynecol Oncol. 1995 Jun;57(3):286-93. doi: 10.1006/gyno.1995.1144. Gynecol Oncol. 1995. PMID: 7774831 Clinical Trial.

7

Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines.

Adler LM, Herzog TJ, Williams S, Rader JS, Mutch DG. Adler LM, et al. Among authors: herzog tj. Cancer. 1994 Oct 1;74(7):1891-8. doi: 10.1002/1097-0142(19941001)74:7<1891::aid-cncr2820740711>3.0.co;2-k. Cancer. 1994. PMID: 7915965

8

Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery.

Massad LS, Vogler G, Herzog TJ, Mutch DG. Massad LS, et al. Among authors: herzog tj. Gynecol Oncol. 1993 Nov;51(2):214-8. doi: 10.1006/gyno.1993.1275. Gynecol Oncol. 1993. PMID: 8276297

9

The role of tumor necrosis factor receptors in tumor necrosis factor-alpha-mediated cytolysis of ovarian cancer cell lines.

Kost ER, Herzog TJ, Adler LM, Williams S, Mutch DG. Kost ER, et al. Among authors: herzog tj. Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):145-53. doi: 10.1016/s0002-9378(96)70387-3. Am J Obstet Gynecol. 1996. PMID: 8571998

10

Growth modulatory effects of granulocyte-macrophage colony-stimulating factor on human cell lines derived from gynecologic malignancies.

Herzog TJ, Horiuchi TK, Williams S, Camel HM, Mutch DG. Herzog TJ, et al. Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):161-8. doi: 10.1016/s0002-9378(96)70389-7. Am J Obstet Gynecol. 1996. PMID: 8572001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters